Bolt Biotherapeutics, Inc.
BOLT
$0.365
-$0.005-1.35%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -15.94M | -15.18M | -21.20M | -10.81M | -17.90M |
| Total Depreciation and Amortization | 426.00K | 440.00K | 457.00K | 458.00K | 467.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.28M | 1.35M | 2.82M | 2.04M | 1.63M |
| Change in Net Operating Assets | -1.20M | -578.00K | 1.77M | -8.44M | 1.54M |
| Cash from Operations | -14.43M | -13.97M | -16.14M | -16.75M | -14.27M |
| Capital Expenditure | 0.00 | -41.00K | -- | -- | -6.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 148.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 12.23M | 17.03M | 18.00M | 10.20M | 15.82M |
| Cash from Investing | 12.23M | 17.14M | 18.00M | 10.20M | 15.81M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 29.00K | 0.00 | 79.00K | -- | 106.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 29.00K | 0.00 | 79.00K | -- | 106.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.17M | 3.17M | 1.94M | -6.55M | 1.65M |